Majedie Investments (MAJE) Competitors GBX 228 0.00 (0.00%) (As of 08:28 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades MAJE vs. JPGI, FSFL, POLR, CGI, IPO, ATR, PCGH, IPX, GHE, and JUGIShould you be buying Majedie Investments stock or one of its competitors? The main competitors of Majedie Investments include Jpmorgan Global Growth & Income (JPGI), Foresight Solar (FSFL), Polar Capital (POLR), Canadian General Investments (CGI), IP Group (IPO), Schroder Asian Total Return Inv. (ATR), Polar Capital Glb Healthcare (PCGH), Impax Asset Management Group (IPX), Gresham House (GHE), and JPMorgan UK Small Cap Growth & Income (JUGI). These companies are all part of the "asset management" industry. Majedie Investments vs. Jpmorgan Global Growth & Income Foresight Solar Polar Capital Canadian General Investments IP Group Schroder Asian Total Return Inv. Polar Capital Glb Healthcare Impax Asset Management Group Gresham House JPMorgan UK Small Cap Growth & Income Majedie Investments (LON:MAJE) and Jpmorgan Global Growth & Income (LON:JPGI) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation, community ranking and media sentiment. Do insiders and institutionals have more ownership in MAJE or JPGI? 15.3% of Majedie Investments shares are held by institutional investors. 63.7% of Majedie Investments shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings and valuation, MAJE or JPGI? Majedie Investments has higher earnings, but lower revenue than Jpmorgan Global Growth & Income. Jpmorgan Global Growth & Income is trading at a lower price-to-earnings ratio than Majedie Investments, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMajedie Investments£18.33M6.59£17.11M£0.31735.48Jpmorgan Global Growth & Income£93.27M5.07N/A£67.805.01 Does the media prefer MAJE or JPGI? In the previous week, Majedie Investments had 2 more articles in the media than Jpmorgan Global Growth & Income. MarketBeat recorded 2 mentions for Majedie Investments and 0 mentions for Jpmorgan Global Growth & Income. Majedie Investments' average media sentiment score of 1.03 beat Jpmorgan Global Growth & Income's score of 0.00 indicating that Majedie Investments is being referred to more favorably in the media. Company Overall Sentiment Majedie Investments Positive Jpmorgan Global Growth & Income Neutral Does the MarketBeat Community favor MAJE or JPGI? Jpmorgan Global Growth & Income received 4 more outperform votes than Majedie Investments when rated by MarketBeat users. However, 71.01% of users gave Majedie Investments an outperform vote while only 68.00% of users gave Jpmorgan Global Growth & Income an outperform vote. CompanyUnderperformOutperformMajedie InvestmentsOutperform Votes9871.01% Underperform Votes4028.99% Jpmorgan Global Growth & IncomeOutperform Votes10268.00% Underperform Votes4832.00% Is MAJE or JPGI a better dividend stock? Majedie Investments pays an annual dividend of GBX 8 per share and has a dividend yield of 3.5%. Jpmorgan Global Growth & Income pays an annual dividend of GBX 0.13 per share and has a dividend yield of 0.0%. Majedie Investments pays out 2,580.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Jpmorgan Global Growth & Income pays out 0.2% of its earnings in the form of a dividend. Do analysts rate MAJE or JPGI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Majedie Investments 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AJpmorgan Global Growth & Income 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is MAJE or JPGI more profitable? Majedie Investments has a net margin of 93.30% compared to Jpmorgan Global Growth & Income's net margin of 0.00%. Majedie Investments' return on equity of 12.53% beat Jpmorgan Global Growth & Income's return on equity.Company Net Margins Return on Equity Return on Assets Majedie Investments93.30% 12.53% 6.25% Jpmorgan Global Growth & Income N/A N/A N/A SummaryMajedie Investments beats Jpmorgan Global Growth & Income on 11 of the 15 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get Majedie Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for MAJE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAJE vs. The Competition Export to ExcelMetricMajedie InvestmentsAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£120.84M£772.07M£3.14B£1.40BDividend Yield3.50%13.41%4.64%11.76%P/E Ratio735.48747.36430.551,563.48Price / Sales6.5913,590.652,955.28211,032.80Price / Cash11.0178.8347.9332.98Price / Book0.841.692.272.85Net Income£17.11M£57.11M£394.92M£152.89M7 Day PerformanceN/A0.25%6.32%4.77%1 Month Performance-6.56%-0.64%0.10%3.31%1 Year Performance4.35%12.25%16.43%106.47% Majedie Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAJEMajedie InvestmentsN/AGBX 228flatN/A+3.3%£120.84M£18.33M735.483Dividend IncreasePositive NewsJPGIJpmorgan Global Growth & IncomeN/AN/AN/AN/A£472.52M£93.27M5.01N/AHigh Trading VolumeFSFLForesight SolarN/AGBX 82.40-0.7%N/A-7.2%£468.14M£28.20M-4,120.00N/ADividend AnnouncementHigh Trading VolumePOLRPolar Capital1.8901 of 5 starsN/AGBX 542.50+∞N/A£464.11M£197.25M1,142.86135Gap UpCGICanadian General InvestmentsN/AGBX 2,220+3.7%N/A+11.7%£463.09M£201.31M509.17N/AGap UpIPOIP Group2.899 of 5 starsGBX 45.60-0.5%GBX 126+176.3%-7.1%£453.71M£-212,500,000.00-207.2795Gap UpATRSchroder Asian Total Return Inv.N/AGBX 473-0.4%N/A+18.8%£452.85M£41.66M1,351.4313,500Positive NewsPCGHPolar Capital Glb HealthcareN/AGBX 373+0.5%N/A+25.6%£452.34MN/A4,144.44N/ADividend IncreaseIPXImpax Asset Management Group3.2708 of 5 starsGBX 353+0.6%GBX 560+58.6%-16.9%£451.70M£176.56M1,138.71300Dividend IncreasePositive NewsGHEGresham HouseN/AN/AN/AN/A£451.55M£86.03M3,055.56216JUGIJPMorgan UK Small Cap Growth & IncomeN/AGBX 324-0.3%N/AN/A£445.27M£104.52M334.02N/ADividend AnnouncementPositive News Related Companies and Tools Related Companies Jpmorgan Global Growth & Income Competitors Foresight Solar Competitors Polar Capital Competitors Canadian General Investments Competitors IP Group Competitors Schroder Asian Total Return Inv. Competitors Polar Capital Glb Healthcare Competitors Impax Asset Management Group Competitors Gresham House Competitors JPMorgan UK Small Cap Growth & Income Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:MAJE) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Majedie Investments Please log in to your account or sign up in order to add this asset to your watchlist. Share Majedie Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
